Source-grounded facts extracted from NOVAVAX INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Richard J. Rodgers was appointed as Director at NOVAVAX INC.
“On October 29, 2022, the Board of Directors (the “Board”) of Novavax, Inc. (the “Company”) voted to increase the size of the Board from seven members to eight members and to appoint Richard J. Rodgers to the Board to fill the resulting vacancy, effective as of October 29, 2022.”
Rajiv I. Modi resigned as Director at NOVAVAX INC.
“Rajiv I. Modi, Ph.D. notified the Board of Directors (the "Board") of Novavax, Inc. of his resignation from the Board, effective immediately.”
James P. Kelly was appointed as Executive Vice President, Chief Financial Officer and Treasurer at NOVAVAX INC.
“announced the appointment of James P. Kelly, age 55, as Executive Vice President, Chief Financial Officer and Treasurer of the Company, effective August 16, 2021.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.